CMC Biologics
Biotechnology ResearchDenmark501-1000 Employees
CMC Biologics is a global contract manufacturing organization in the biotechnology research sector, operating three biomanufacturing facilities across Europe and the United States. The company provides a full spectrum of cGMP biologics manufacturing for both commercial and clinical applications, spanning from DNA to the active pharmaceutical ingredient. Its services can be delivered as turnkey manufacturing or as targeted, stand-alone capabilities in analytics, formulation, and stability. Headquartered in Denmark, CMC Biologics serves clients developing biologics and seeks to align its projects with each client's specific requirements. The firm licenses CHEF1, a non-exclusive CHO cell line development platform, which supports stable, high-titer cell lines within optimized timeframes and informs its cell line and process development approach.